Immediate Impact
53 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Works of Sayed Ali being referenced
Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)
2017
Metformin in prostate cancer: two for the price of one
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sayed Ali | 299 | 182 | 132 | 24 | 515 | |
| Myla Lai-Goldman | 253 | 144 | 93 | 14 | 467 | |
| Monika Lamba Saini | 257 | 261 | 113 | 29 | 642 | |
| Nathan D. Seligson | 202 | 181 | 156 | 38 | 502 | |
| E. E. Holdener | 186 | 254 | 126 | 16 | 599 | |
| Roberta Sarmiento | 231 | 189 | 71 | 19 | 582 | |
| R. H. Bottomley | 164 | 193 | 80 | 27 | 590 | |
| Agnès Legrand | 119 | 194 | 49 | 24 | 489 | |
| Tomoko Ota | 189 | 158 | 50 | 22 | 491 | |
| J. Maroun | 270 | 201 | 85 | 30 | 598 | |
| M Fukushima | 338 | 151 | 235 | 36 | 628 |
All Works
Login with ORCID to disown or claim papers
Loading papers...